DESIGN AND SYNTHESIS OF NOVEL MMP-2 INHIBITORS WITH HYDROXAMATE AND OXADIAZOLE UNITS AS ZINC BINDING GROUPS

被引:0
|
作者
Puckowska, Anna [1 ,2 ]
Bruczko, Marta [1 ,3 ]
Maria Zapico, Jose [1 ]
Serra, Pilar [1 ]
Martin-Santamaria, Sonsoles [1 ]
de Pascual-Teresa, Beatriz [1 ]
Ramos, Ana [1 ]
机构
[1] Univ San Pablo CEU, Fac Pharm, Dept Organ Chem, Madrid, Spain
[2] Med Univ Bialystok, Fac Pharm, Dept Organ Chem, Bialystok, Poland
[3] Med Univ Bialystok, Dept Med Chem, Bialystok, Poland
关键词
PROGRESS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:172 / 172
页数:1
相关论文
共 50 条
  • [31] Design, synthesis and evaluation of novel azasugar-based MMP/ADAM inhibitors
    Moriyama, H
    Tsukida, T
    Inoue, Y
    Kondo, H
    Yoshino, K
    Nishimura, SI
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (16) : 2741 - 2744
  • [32] Design, synthesis, and biological activity of novel, potent, and highly selective fused pyrimidine-2-carboxamide-4-one-based matrix metalloproteinase (MMP)-13 zinc-binding inhibitors
    Nara, Hiroshi
    Sato, Kenjiro
    Kaieda, Akira
    Oki, Hideyuki
    Kuno, Haruhiko
    Santou, Takashi
    Kanzaki, Naoyuki
    Terauchi, Jun
    Uchikawa, Osamu
    Kori, Masakuni
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (23) : 6149 - 6165
  • [33] Azetidinones as Zinc-Binding Groups to Design Selective HDAC8 Inhibitors
    Galletti, Paola
    Quintavalla, Arianna
    Ventrici, Caterina
    Giannini, Giuseppe
    Cabri, Walter
    Penco, Sergio
    Gallo, Grazia
    Vincenti, Silvia
    Giacomini, Daria
    CHEMMEDCHEM, 2009, 4 (12) : 1991 - 2001
  • [34] Novel matrix metalloproteinase inhibitors based on hydroxypyridinone zinc-binding groups.
    Lewis, JA
    Puerta, DT
    Cohen, SM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U1047 - U1047
  • [35] Design, parallel chemical synthesis and in vitro characterization of novel hydroxamate-based prostaglandin H2 synthase inhibitors
    Lee, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2670 - U2671
  • [36] HDAC4 Inhibitors with Cyclic Linker and Non-hydroxamate Zinc Binding Group: Design, Synthesis, HDAC Screening and in vitro Cytotoxicity evaluation.
    Tilekar, Kalpana
    Hess, Jessica D.
    Upadhyay, Neha
    Schweipert, Markus
    Flath, Felix
    Gutierrez, Denisse A.
    Loiodice, Fulvio
    Lavecchia, Antonio
    Meyer-Almes, Franz-Josef
    Aguilera, Renato J.
    Ramaa, C. S.
    CHEMISTRYSELECT, 2021, 6 (26): : 6748 - 6763
  • [37] Synthesis and bioactivity of novel C2-glycosyl oxadiazole derivatives as acetylcholinesterase inhibitors
    Wang, Lei
    Wu, Yu-Ran
    Ren, Shu-Ting
    Yin, Long
    Liu, Xiu-Jian
    Cheng, Feng-Chang
    Liu, Wei-Wei
    Shi, Da-Hua
    Cao, Zhi-Ling
    Sun, Hui-Min
    HETEROCYCLIC COMMUNICATIONS, 2018, 24 (06) : 333 - 338
  • [38] Design, Synthesis, and Docking Study of Acyl Thiourea Derivatives as Possible Histone Deacetylase Inhibitors with a Novel Zinc Binding Group
    Al-Amily, Duraid
    Mohammed, Mohammed H.
    SCIENTIA PHARMACEUTICA, 2019, 87 (04)
  • [39] Design, synthesis, and evaluation of novel inhibitors of core-binding factor β.
    Gorczynski, MJ
    Chinigo, G
    Corpora, T
    Bushweller, JH
    Brown, ML
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U187 - U187
  • [40] Novel substituted oxadiazole - piperazine derivatives as potential MAO inhibitors: Design, synthesis, in vitro and in silico studies
    Uslu, Harun
    Saglik, Begum Nurpelin
    Osmaniye, Derya
    Benkli, Kadriye
    JOURNAL OF RESEARCH IN PHARMACY, 2022, 26 (01): : 20 - 27